Catalyst Wire Dossier Catalyst Wire Dossier

Ulonivirine

MK-8507 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ulonivirine, covering 2025-02-18 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) [Phase 2, Phase 3]

See pricing